Med-Design cannot pinpoint share price drop trigger?:
This article was originally published in Clinica
Med-Design, which is currently negotiating licences for its retractable safety needle technology, says it is unaware of any fundamental reason for the recent decline in the price of its shares. The US company says it has had a positive response from potential licensees and that the sale of its shares appears to be due to "technical conditions associated with the liquidation of margin debt". Around one million needlestick accidents occur in the US each year, according to the American Hospital Association.
You may also be interested in...
The head of the European Medicines Agency is nearing the end of his tenure. We consider Guido Rasi’s achievements over the past 10 years as well as the controversies that have arisen under his leadership – and report that sailing is likely to figure in his plans for life after the agency.
Can shaving ever be “friction free”? Not according to Procter & Gamble, which challenged in a complaint to the UK Advertising Standards Authority a claim made by a British cosmetics firm FFS that it provided a “friction free” shaving experience for women via its subscription razor service.